High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of recurrent glioblastoma


Glioblastoma Multiforme (GBM) is the most common primary brain tumour in adults, yet survival outcomes remain poor. First line treatment is well established but with disease recurrence almost inevitable, improving prognosis... [ view full abstract ]


  1. Jessica Taylor (University of Manchester)
  2. Kenny Yu (University of Manchester)
  3. Omar Pathmanaban (University of Manchester)
  4. Deniz Beyit (Imagen Therapeutics)
  5. Joanna Dutko-Gwozdz (Imagen Therapeutics)
  6. Rod Benson (Imagen Therapeutics)
  7. Gareth Griffiths (Imagen Therapeutics)
  8. Catherine McBain (The Christie Hospital)
  9. Ian Peers (Inferstats Consulting)
  10. Peter Ceuppens (Inferstats Consulting)
  11. Ian Kamaly-asl (Royal Manchester Children's Hospital)
  12. Brian Bigger (University of Manchester)

Topic Areas

Laboratory and Clinical Science , Adult Gliomas


OS-22A » Parallel Session A: Science (09:40 - Thursday, 22nd June, Pentland East)

Presentation Files

The presenter has not uploaded any presentation files.